I agree that this site is using cookies. You can find further informations here.
X
Kantecki, Michal
38  results:
Search for persons X
?
1

Ceftaroline fosamil treatment patterns and outcomes in adul..:

Soriano, Alex ; Bassetti, Matteo ; Gogos, Charalambos...
JAC-Antimicrobial Resistance.  6 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

In vitro activity of aztreonam-avibactam and comparators ag..:

Rossolini, Gian Maria ; Arhin, Francis F. ; Kantecki, Michal
Journal of Global Antimicrobial Resistance.  36 (2024)  - p. 123-131 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Ceftaroline Fosamil as a Potential Treatment for Central Ne..:

Bradley, John S. ; Cattaneo, Dario ; Kantecki, Michal.
Infectious Diseases in Clinical Practice.  32 (2024)  4 - p. , 2024
Link: https://doi.org/10.1097/..
 
?
4

Real-World Use and Treatment Outcomes of Ceftaroline Fosami..:

Ferry, Tristan ; Gogos, Charalambos ; Soriano, Alex...
Infection and Drug Resistance.  17 (2024)  - p. 2773-2783 , 2024
Link: https://doi.org/10.2147/..
 
?
5

Antimicrobial Activities of Aztreonam-Avibactam and Compara..:

Piérard, Denis ; Hermsen, Elizabeth D. ; Kantecki, Michal.
Antibiotics.  12 (2023)  11 - p. 1591 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Evaluation of in vitro activity of ceftaroline against path..:

Utt, Eric ; Kantecki, Michal ; Cabezas-Camarero, Guillermo.
Journal of Global Antimicrobial Resistance.  33 (2023)  - p. 360-367 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Treatment outcomes of secondary bacteraemia in patients tre..:

Dryden, Matthew ; Kantecki, Michal ; Yan, Jean Li...
Journal of Global Antimicrobial Resistance.  28 (2022)  - p. 108-114 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Ceftaroline Fosamil for the Empiric Treatment of Hospitaliz..:

Torres, Antoni ; Soriano, Alex ; Rivolo, Simone...
ClinicoEconomics and Outcomes Research.  14 (2022)  - p. 149-161 , 2022
Link: https://doi.org/10.2147/..
 
?
9

In vitro activity of aztreonam/avibactam against isolates o..:

Rossolini, Gian Maria ; Stone, Gregory ; Kantecki, Michal.
Journal of Global Antimicrobial Resistance.  30 (2022)  - p. 214-221 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Correction to: Ceftaroline Fosamil for Treatment of Pediatr..:

Esposito, Susanna ; Carrothers, Timothy J. ; Riccobene, Todd..
Pediatric Drugs.  23 (2021)  6 - p. 615-615 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Impact of Underlying Comorbidities on Outcomes of Patients ..:

Wilcox, Mark ; Yan, Jean Li ; Gonzalez, Pedro L....
Infectious Diseases and Therapy.  11 (2021)  1 - p. 217-230 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Ceftaroline Fosamil for Treatment of Pediatric Complicated ..:

Esposito, Susanna ; Carrothers, Timothy J. ; Riccobene, Todd..
Pediatric Drugs.  23 (2021)  6 - p. 549-563 , 2021
Link: https://doi.org/10.1007/..
 
?
13

Baseline Characteristics and Outcomes Among Patients with C..:

Sánchez-García, Miguel ; Hammond, Jennifer ; Yan, Jean Li...
Infectious Diseases and Therapy.  9 (2020)  3 - p. 609-623 , 2020
Link: https://doi.org/10.1007/..
 
?
14

Ceftaroline fosamil as a potential treatment option for Sta..:

Welte, Tobias ; Kantecki, Michal ; Stone, Gregory G..
International Journal of Antimicrobial Agents.  54 (2019)  4 - p. 410-422 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Safety and Efficacy of Anidulafungin for Fungal Infection i..:

Verma, Anita ; Auzinger, Georg ; Kantecki, Michal...
Open Forum Infectious Diseases.  4 (2016)  1 - p. , 2016
Link: https://doi.org/10.1093/..
 
1-15